541400.BO
Zim Laboratories Ltd
Price:  
89.25 
INR
Volume:  
1,500
India | Pharmaceuticals

541400.BO WACC - Weighted Average Cost of Capital

The WACC of Zim Laboratories Ltd (541400.BO) is 14.4%.

The Cost of Equity of Zim Laboratories Ltd (541400.BO) is 15%.
The Cost of Debt of Zim Laboratories Ltd (541400.BO) is 13.05%.

RangeSelected
Cost of equity13.8% - 16.2%15%
Tax rate29.7% - 30.6%30.15%
Cost of debt12.7% - 13.4%13.05%
WACC13.3% - 15.5%14.4%
WACC

541400.BO WACC calculation

CategoryLowHigh
Long-term bond rate7.4%7.9%
Equity market risk premium6.9%7.9%
Adjusted beta0.920.98
Additional risk adjustments0.0%0.5%
Cost of equity13.8%16.2%
Tax rate29.7%30.6%
Debt/Equity ratio
0.110.11
Cost of debt12.7%13.4%
After-tax WACC13.3%15.5%
Selected WACC14.4%

541400.BO's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 541400.BO:

cost_of_equity (15.00%) = risk_free_rate (7.65%) + equity_risk_premium (7.40%) * adjusted_beta (0.92) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.